Systems analysis of miR-199a/b-5p and multiple miR-199a/b-5p targets during chondrogenesis.

bioinformatics chondrogenesis computational biology human kinetic modelling microRNA mouse osteoarthritis systems biology

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
14 Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Changes in chondrocyte gene expression can contribute to the development of osteoarthritis (OA), and so recognition of the regulative processes during chondrogenesis can lead to a better understanding of OA. microRNAs (miRNAs) are key regulators of gene expression in chondrocytes/OA, and we have used a combined experimental, bioinformatic, and systems biology approach to explore the multiple miRNA-mRNA interactions that regulate chondrogenesis. A longitudinal chondrogenesis bioinformatic analysis identified paralogues miR-199a-5p and miR-199b-5p as pro-chondrogenic regulators. Experimental work in human cells demonstrated alteration of miR-199a-5p or miR-199b-5p expression led to significant inverse modulation of key chondrogenic genes and extracellular matrix production. miR-199a/b-5p targets

Identifiants

pubmed: 39401064
doi: 10.7554/eLife.89701
pii: 89701
doi:
pii:

Substances chimiques

MicroRNAs 0
mirn199 microRNA, human 0

Banques de données

GEO
['GSE274379', 'GSE18394', 'GSE109503']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Dunhill Medical Trust
ID : R476/0516
Organisme : Novo Nordisk Fonden
ID : NNF17OC0027812
Organisme : Versus Arthritis
ID : MR/P020941/1
Pays : United Kingdom
Organisme : Versus Arthritis
ID : MR/R502182/1
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 22043
Pays : United Kingdom

Informations de copyright

© 2023, Patel, Barter et al.

Déclaration de conflit d'intérêts

KP, MB, JS, PC, CP, IC, DY, DS No competing interests declared

Auteurs

Krutik Patel (K)

Campus for Ageing and Vitality, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.

Matt Barter (M)

Regenerative Medicine, Stem Cells, Transplantation, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

Jamie Soul (J)

Regenerative Medicine, Stem Cells, Transplantation, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Computational Biology Facility, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.

Peter Clark (P)

Campus for Ageing and Vitality, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.

Carole Proctor (C)

Campus for Ageing and Vitality, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.

Ian Clark (I)

School of Biological Sciences, University of East Anglia, Norwich, United Kingdom.

David Young (D)

Regenerative Medicine, Stem Cells, Transplantation, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

Daryl P Shanley (DP)

Campus for Ageing and Vitality, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH